首页> 外国专利> Method for predicting the responsiveness to treatment with rivastigmine based on the ApoE genotyp of dementia patients

Method for predicting the responsiveness to treatment with rivastigmine based on the ApoE genotyp of dementia patients

机译:基于痴呆患者ApoE基因型预测卡巴拉汀对治疗反应的方法

摘要

This invention relates to methods to prevent worsening of and/or to improve cognitive functioning and behaviour problems in patients with dementia by means of ApoE genotyping to guide the use of AChEI drugs, including rivastigmine. Also included are kits for determining ApoE4 status and recommended treatment strategy.
机译:本发明涉及通过ApoE基因分型来指导AChEI药物,包括rivastigmine的使用,以预防和/或改善痴呆患者的认知功能和行为问题的方法。还包括确定ApoE4状态的试剂盒和推荐的治疗策略。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号